Zoltan Dekan

1.8k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Zoltan Dekan is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Zoltan Dekan has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Genetics and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Zoltan Dekan's work include Nicotinic Acetylcholine Receptors Study (18 papers), Ion channel regulation and function (16 papers) and Venomous Animal Envenomation and Studies (13 papers). Zoltan Dekan is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (18 papers), Ion channel regulation and function (16 papers) and Venomous Animal Envenomation and Studies (13 papers). Zoltan Dekan collaborates with scholars based in Australia, United States and France. Zoltan Dekan's co-authors include Paul F. Alewood, Richard J. Lewis, Irina Vetter, Glenn F. King, Jennifer R. Deuis, Markus Muttenthaler, Mehdi Mobli, Volker Herzig, Aline D. de Araujo and Stuart M. Brierley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Zoltan Dekan

36 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain

2016 238 citations Jeremiah D. Osteen, Volker Herzig et al. Nature profile →

Peers

Countries citing papers authored by Zoltan Dekan

Since Specialization

Citations

This map shows the geographic impact of Zoltan Dekan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltan Dekan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltan Dekan more than expected).

Fields of papers citing papers by Zoltan Dekan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltan Dekan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltan Dekan. The network helps show where Zoltan Dekan may publish in the future.

Co-authorship network of co-authors of Zoltan Dekan

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltan Dekan. A scholar is included among the top collaborators of Zoltan Dekan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltan Dekan. Zoltan Dekan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TDT: a highly potent and stable chimeric natriuretic peptide for heart failure treatment 2025 ·Australian Journal of Chemistry ·(unknown), Zoltan Dekan, Sandra L. Burke, Andreas Brust, (unknown), (unknown), Geoffrey A. Head, (unknown)	0
2	Novel Scorpion Toxin ω-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via CaV3.3 and CaV3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain 2024 ·International Journal of Molecular Sciences ·Dan Wang, Volker Herzig, Zoltan Dekan, K. Johan Rosengren, (unknown), (unknown), Zhuang Jing, Emmanuel Bourinet, Lotten Ragnarsson, Paul F. Alewood, Richard J. Lewis	3
3	Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor 2022 ·ACS Chemical Neuroscience ·Patrick Wilhelm, Karen Luna-Ramírez, Yanni K.‐Y. Chin, Zoltan Dekan, (unknown), Han‐Shen Tae, Chun Yuen Chow, (unknown), Glenn F. King, Richard J. Lewis, David J. Adams, Paul F. Alewood	2
4	The Tarantula Venom Peptide Eo1a Binds to the Domain II S3-S4 Extracellular Loop of Voltage-Gated Sodium Channel NaV1.8 to Enhance Activation 2022 ·Frontiers in Pharmacology ·Jennifer R. Deuis, Lotten Ragnarsson, Samuel D. Robinson, Zoltan Dekan, (unknown), Aihua Jin, (unknown), (unknown), Shengnan Li, John N. Wood, James J. Cox, Glenn F. King, Volker Herzig, Irina Vetter	9
5	Production, composition, and mode of action of the painful defensive venom produced by a limacodid caterpillar, Doratifera vulnerans 2021 ·Proceedings of the National Academy of Sciences ·Andrew A. Walker, Samuel D. Robinson, Jean‐Paul Paluzzi, David J. Merritt, (unknown), Christina I. Schroeder, Jiayi Jin, (unknown), Andrew C. Kotze, Zoltan Dekan, Andy Sombke, Paul F. Alewood, Bryan G. Fry, Marc E. Epstein, Irina Vetter, Glenn F. King	22
6	Olfactory bulb‐targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice 2020 ·Journal of Neurochemistry ·(unknown), Anshika Kapur, Zhenbo Huang, Raveendra Anangi, (unknown), Scott M. Stagg, (unknown), Zoltan Dekan, Jens Rosenberg, Samuel C. Grant, Glenn F. King, Hedi Mattoussi, Debra Ann Fadool	16
7	Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target NaV1.7 2020 ·Biochemical Pharmacology ·(unknown), Volker Herzig, Irina Vetter, Zoltan Dekan, John M. Gilchrist, Frank Bosmans, Paul F. Alewood, Richard J. Lewis, Glenn F. King	7
8	The α1-adrenoceptor inhibitor ρ-TIA facilitates net hunting in piscivorous Conus tulipa 2019 ·Scientific Reports ·Mriga Dutt, Jean Giacomotto, Lotten Ragnarsson, Åsa Andersson, Andreas Brust, Zoltan Dekan, Paul F. Alewood, Richard J. Lewis	6
9	Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen 2019 ·Pain ·Alexander Mueller, Hana Starobova, Michael Morgan, Zoltan Dekan, Olivier Cheneval, Christina I. Schroeder, Paul F. Alewood, Jennifer R. Deuis, Irina Vetter	43
10	PHAB toxins: a unique family of predatory sea anemone toxins evolving via intra-gene concerted evolution defines a new peptide fold 2018 ·Cellular and Molecular Life Sciences ·Bruno Madio, Steve Peigneur, Yanni K.‐Y. Chin, Brett R. Hamilton, Sónia Troeira Henriques, Jennifer J. Smith, Ben Cristofori‐Armstrong, Zoltan Dekan, Berin A. Boughton, Paul F. Alewood, Jan Tytgat, Glenn F. King, Eivind A. B. Undheim	39
11	Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target 2018 ·Biochemical Pharmacology ·Linlin Ma, Yanni K.‐Y. Chin, Zoltan Dekan, Volker Herzig, Chun Yuen Chow, (unknown), (unknown), Gilles J. Guillemin, Paul F. Alewood, Glenn F. King	17
12	Modulatory features of the novel spider toxin μ‐TRTX‐Df1a isolated from the venom of the spider Davus fasciatus 2017 ·British Journal of Pharmacology ·Fernanda C. Cardoso, Zoltan Dekan, Jennifer J. Smith, Jennifer R. Deuis, Irina Vetter, Volker Herzig, Paul F. Alewood, Glenn F. King, Richard J. Lewis	44
13	Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain breakdown → 2016 ·Nature ·Jeremiah D. Osteen, Volker Herzig, John M. Gilchrist, Joshua J. Emrick, Chuchu Zhang, Xidao Wang, Joel Castro, Sonia Garcia‐Caraballo, Luke Grundy, Grigori Y. Rychkov, Andy Weyer, Zoltan Dekan, Eivind A. B. Undheim, Paul F. Alewood, Cheryl L. Stucky, Stuart M. Brierley, Allan I. Basbaum, Frank Bosmans, Glenn F. King, David Julius	238
14	Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens 2015 ·Molecular Pharmacology ·Fernanda C. Cardoso, Zoltan Dekan, K. Johan Rosengren, Andelain Erickson, Irina Vetter, Jennifer R. Deuis, Volker Herzig, Paul F. Alewood, Glenn F. King, Richard J. Lewis	67
15	Xenopus borealis as an alternative source of oocytes for biophysical and pharmacological studies of neuronal ion channels 2015 ·Scientific Reports ·Ben Cristofori‐Armstrong, (unknown), Sahil Talwar, Darren L. Brown, (unknown), Zoltan Dekan, Jennifer L. Stow, Glenn F. King, Joseph W. Lynch, Lachlan D. Rash	14
16	A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating Domain 2014 ·Current Biology ·Junhong Gui, Boyi Liu, Guan Cao, Andrew M. Lipchik, (unknown), Zoltan Dekan, Mehdi Mobli, Norelle L. Daly, Paul F. Alewood, Laurie L. Parker, Glenn F. King, Yufeng Zhou, Sven‐Eric Jordt, Michael N. Nitabach	54
17	Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain 2014 ·Nature Communications ·Aline D. de Araujo, Mehdi Mobli, Joel Castro, Andrea M. Harrington, Irina Vetter, Zoltan Dekan, Markus Muttenthaler, Jingjing Wan, Richard J. Lewis, Glenn F. King, Stuart M. Brierley, Paul F. Alewood	118
18	Conotoxin engineering: dual pharmacophoric noradrenaline transport inhibitor/integrin binding peptide with improved stability 2012 ·Organic & Biomolecular Chemistry ·Zoltan Dekan, (unknown), Robert K. Andrews, Richard J. Lewis, Paul F. Alewood	13
19	Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels 2012 ·Biochemical Pharmacology ·Irina Vetter, Zoltan Dekan, Oliver Knapp, David J. Adams, Paul F. Alewood, Richard J. Lewis	52
20	α-Conotoxin ImI Incorporating Stable Cystathionine Bridges Maintains Full Potency and Identical Three-Dimensional Structure 2011 ·Journal of the American Chemical Society ·Zoltan Dekan, Irina Vetter, Norelle L. Daly, David J. Craik, Richard J. Lewis, Paul F. Alewood	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact